682 related articles for article (PubMed ID: 19254701)
1. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
[TBL] [Abstract][Full Text] [Related]
3. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
5. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
6. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
7. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
Nakhate KT; Yedke SU; Bharne AP; Subhedar NK; Kokare DM
Brain Res; 2016 Sep; 1646():1-11. PubMed ID: 27208493
[TBL] [Abstract][Full Text] [Related]
9. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
10. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Morales-Medina JC; Dumont Y; Benoit CE; Bastianetto S; Flores G; Fournier A; Quirion R
Neuropharmacology; 2012 Jan; 62(1):200-8. PubMed ID: 21803058
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
12. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
13. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats.
Goyal SN; Kokare DM; Chopde CT; Subhedar NK
Pharmacol Biochem Behav; 2006 Oct; 85(2):369-77. PubMed ID: 17052748
[TBL] [Abstract][Full Text] [Related]
14. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.
Morales-Medina JC; Dominguez-Lopez S; Gobbi G; Beck-Sickinger AG; Quirion R
Behav Brain Res; 2012 Aug; 233(2):298-304. PubMed ID: 22613731
[TBL] [Abstract][Full Text] [Related]
15. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
[TBL] [Abstract][Full Text] [Related]
16. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Eur J Pharmacol; 2009 May; 609(1-3):78-87. PubMed ID: 19285064
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Desai SJ; Borkar CD; Nakhate KT; Subhedar NK; Kokare DM
Neuroscience; 2014 Sep; 277():818-30. PubMed ID: 25106129
[TBL] [Abstract][Full Text] [Related]
18. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Redrobe JP; Dumont Y; Fournier A; Quirion R
Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
[TBL] [Abstract][Full Text] [Related]
19. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
